In vitro activity of dirithromycin against Chlamydia trachomatis.
Dirithromycin is a new macrolide antibiotic with an active metabolite, erythromycylamine. We evaluated the in vitro activities of both drugs against 16 isolates of Chlamydia trachomatis and compared them with that of doxycycline. In vitro susceptibility testing was performed with McCoy cell monolaye...
שמור ב:
| הוצא לאור ב: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1994
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284716/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7811051/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.9.2213 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|